News
Latest news from CHV and our portfolio companies
Featured News
January 20, 2026, Boston, MA: Catalyst Health Ventures (CHV), a venture capital firm focused on advancing transformative medical technologies, today announced the promotion of David Mackey to Partner. Mackey has…
Insights & Impacts: The latest from CHV
Innovative Leader in AI-Powered Brain Health Solutions Strengthens Board with Accomplished Remote Patient Monitoring Executive
After promising results from first-in-man studies with its novel Neural Ice™ technology, the Massachusetts-based company
AtaCor Medical Inc., a privately-held medical device company delivering the next generation of extravascular leads
Advancements help neurologists detect and analyze suspected seizure events from patients in home healthcare settings
Avive Solutions, Inc., the developer of the world’s most advanced connected automated external defibrillator (AED)
Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health
Brixton Biosciences, a clinical-stage life sciences company developing novel therapies for chronic and acute pain,
The round was led by SPRIG Equity with participation from all major Series C investors
Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health
PreTRM® test-and-treat strategy demonstrates statistically and clinically significant improvement in neonatal health outcomes and hospital